BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/30/0.1/20.09.24 Stock

Warrant

0I2NB

NLBNPFR1YMF0

Market Closed - Euronext Paris 12:04:22 2024-05-22 EDT
0.145 EUR +52.63% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/30/0.1/20.09.24
Current month+72.73%
1 month+72.73%
Date Price Change
24-05-22 0.145 +52.63%
24-05-21 0.095 -9.52%
24-05-20 0.105 -8.70%
24-05-17 0.115 -8.00%
24-05-16 0.125 -7.41%

Real-time Euronext Paris

Last update May 22, 2024 at 12:04 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
0I2NB
ISINNLBNPFR1YMF0
Date issued 2024-02-21
Strike 30 $
Maturity 2024-09-20 (121 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.175
Lowest since issue 0.04
Delta0.47x
Omega 8.819
Premium7.84x
Gearing18.63x
Moneyness 0.9758
Difference Strike 0.745 $
Difference Strike %+2.48%
Spread 0.01
Spread %6.67%
Theoretical value 0.1450
Implied Volatility 27.77 %
Total Loss Probability 58.30 %
Intrinsic value 0.000000
Present value 0.1450
Break even 31.57 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.56 USD
Average target price
31.94 USD
Spread / Average Target
+11.83%
Consensus
  1. Stock Market
  2. Warrants
  3. 0I2NB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW